← AI Health Hub

Cardiology 2 min read

Hippocratic AI Collaborates with Burjeel Holdings to Enhance Healthcare in the MENA Region

Hippocratic AI partners with Burjeel Holdings to enhance healthcare delivery in the MENA region using generative AI. ๐Ÿค๐ŸŒ

Yusuf Yesil, MD, MIS
Partnership Overview

Hippocratic AI, a company specializing in generative AI for healthcare, has formed a strategic alliance with Burjeel Holdings, a prominent healthcare services provider based in the United Arab Emirates. This partnership aims to improve healthcare delivery across the Middle East and North Africa (MENA) region.

Key Details of the Partnership
  • The announcement was made during the Abu Dhabi Global Healthcare Week.
  • Hippocratic AI will develop generative AI healthcare agents for patient-facing non-diagnostic clinical tasks.
  • These AI agents will be implemented in Burjeel Holdingsโ€™ healthcare facilities and physiotherapy clinics in the UAE and Oman.
Enhancing Patient Engagement

The integration of Hippocratic AIโ€™s technology is expected to:

  • Transform patient engagement.
  • Facilitate personalized and empathetic clinical conversations.
Multilingual Capabilities

The partnership will also feature:

  • Multilingual AI agents capable of communicating in Arabic, including the Emirati dialect.
  • Support for over 15 languages, such as Spanish, Mandarin, and Vietnamese.
  • Plans to expand language support to cover nearly all major global languages.
Cultural Relevance

The collaboration aims to create:

  • Personalized regional generative AI agents that align with local cultures and needs.
  • AI agents across various specialties, including oncology, cardiology, neurology, and orthopedics.
Statements from Leadership

Munjal Shah, co-founder and CEO of Hippocratic AI, expressed pride in partnering with Burjeel Holdings, stating:

โ€œThis partnership supports our shared mission of achieving healthcare abundance. Our empathic genAI agents are designed to create a more compassionate and effective patient experience.โ€

Recent Developments

In addition to this partnership, Burjeel Holdings recently announced a collaboration with diagnostics company Genalyte to deploy the Merlin automated diagnostic system, pending FDA approval.

Hippocratic AI has also made significant strides, including:

  • Appointing seven new executives following a $141 million Series B funding round.
  • Receiving its first patent for innovations in safety-focused large language models.

This partnership marks a significant step in enhancing healthcare delivery in the MENA region through advanced AI technology.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment.

Yusuf Yesil, MD, MIS
Yusuf Yesil, MD, MIS

Founder & Medical Doctor at Yesil Science. Clinical Biochemistry Specialist and Health AI researcher focused on clinical decision support, diagnostic AI, and biomedical machine learning.

Follow AI Health Hub